SITE MAP 
  HOME  
PHARMA
BIO TECHNOLOGY
MEDICAL TECHNOLOGY
  RESOURCE CENTER  
  JOBS  
  SUBSCRIBE  
 RSS
  Friday, July 3, 2009 SEARCH     
 
BIO AUSTRALIA
BIO CHINA
BIO INDIA
BIO INDONESIA
BIO JAPAN
BIO KOREA
BIO MALAYSIA
BIO NEW ZEALAND
BIO PHILIPPINES
BIO SINGAPORE
BIO TAIWAN
BIO THAILAND
 
Pharmaceutical Technology and Biopharma News
PRIME NEWS
Sosei, Vectura to get milestone payment from Novartis
Pharmaceutical companies Sosei and Vectura have announced the commencement of a phase III clinical study by Novartis, with NVA237.It was licensed to Novartis in April 2005 by Sosei and Vectura
ChemGenex to voluntarily delist from NASDAQ
Australian company, ChemGenex Pharmaceuticals has decided to seek a voluntary delisting from the NASDAQ Capital Market and to fully deregister from the US Securities and Exchange Commission's ongoing reporting obligations
TODAY'S NEWS
  CombinatoRx to merge with Neuromed Pharmaceuticals
  SUA to observe July as Prostate Awareness Month
  KAI Pharma acquires patents from Progen
  "Prostate enlargement is a treatable condition"
  Avexa appoints new Director to Board
  Daiichi Sankyo renames two Chinese subsidiaries
WorldCourier
 
The latest pharmaceutical technology news, trends and analysis, pharma business and investment opportunities, pharmaceutical technology breakthroughs, launch and review of pharma, biopharma & pharmaceutical products, features, event listings and job postings.
 
 
Advertisement
 
Digital Mag
Updated Fortnightly

Issue: June 30, 2009
Current Issue
View / Download
Top Story
Growth slows: Industry grows 18%
 
 
 
Get the latest news on life sciences in your mail box
Name
E-Mail Id
 
 
Advertisement



















 

NEWS
Daiichi Sankyo renames two Chinese subsidiaries
According to the company, the renaming is part of ongoing efforts by the Daiichi Sankyo Group to create a unified and consistent global brand
Astellas submits pediatric data for Flomax capsules in US
Japan's Astellas Pharma has announced that Boehringer Ingelheim Pharmaceuticals has submitted the data for Flomax from a study involving pediatric patients with neurogenic bladder to the US Food and Drug Administration (FDA)
FEATURES
Indonesia insists on local pharma production
The government in Indonesia talks tough on pharma investors, creating a new rule that is aimed at bringing in foreign investment in the sector. The objective is to develop Indonesia as pharma manufacturing hub in South East Asia
Merck's smart emerging market move
The quest for growth in the emerging pharma markets of the world is driving the Big Pharma to look for suitable allies. So the consolidation wave continues, after the Pfizer-Wyeth merger, with another blockbuster $41.1 merger
PEOPLE
Avexa appoints new Director to Board
Australian pharmaceutical company, Avexa has appointed Mr Lawrence Gozlan to its Board of Directors, replacing Dr John Sime who is retiring from the board
Rockwell names Dr Ajay Gupta as CSO
Dr Gupta will be responsible for the identification and development of new drug opportunities in the areas of women's health, oncology and parenteral nutrition as well as new drugs for other targeted renal therapies and indications
EVENTS
SUA to observe July as Prostate Awareness Month
Singapore Urological Association (SUA) and Singapore Cancer Society are observing July as Prostate Awareness Month, starting from July 1 with an objective to call on men 50-75 years old to go for prostate health checks
OPPI takes initiative to encourage pharma innovations in India
As part of its public-private partnership initiative, the Organization of Pharmaceutical Producers of India has collaborated with two premier R&D focused institutions in India, NIPER and CSIR, to encourage innovation in the country
R & D
Concert, GSK ally to develop novel deuterium modified drugs
Concert Pharmaceuticals and GlaxoSmithKline have decided to collaborate to develop and commercialize deuterium-containing medicines
Glenmark's GRC 10693 completes phase I trials
Glenmark Pharmaceuticals, a research-driven, global, integrated pharmaceutical company announced that its candidate for neuropathic pain, osteoarthritis and other inflammatory pain disorders GRC 10693 has successfully completed phase I trials
POLICIES
China Pharma to initiate cholesterol drug clinical trials
China Pharma received official approval from the SFDA of China to enter phase I and phase II clinical trials to test the efficacy of its cholesterol-lowering drug, Rosuvastatin
FDA approves Ilaris to treat rare disease CAPS
The FDA has approved Ilaris (canakinumab) for the treatment of children and adults with cryopyrin-associated periodic syndrome (CAPS), which includes a number of rare but life-long auto-inflammatory disorders with debilitating symptoms
PRODUCTS
Lupin acquires worldwide rights for AllerNaze
Indian pharmaceutical major, Lupin has acquired worldwide rights for the intra-nasal steroid (INS) product, AllerNaze (triamcinolone acetonide, USP) Nasal Spray, 50mcg from Collegium Pharmaceutical
Dr Reddy's launches Bispec in India
According to the company, Bispecm is the best-in-class for the management of Over Active Bladder (OAB) and has lesser incidence of dry mouth and constipation
TRENDS & ANALYSIS
"SalesRep key sources of information in Physicians Info Gathering Process"
Sales force teams are a major focus for the pharmaceutical industry as companies spend a lot of resources to improve their sales force effectiveness, according to RepOptimiser Study conducted by GfK HealthCare Asia among 351 physicians in Malaysia
Seroquel's patient share registers 2% growth: Decision Resources
Decision Resources, a research and advisory firm focusing on pharmaceutical and healthcare issues, says that AstraZeneca Seroquel's first-line patient share grew two percent since last year's patient-level claims data analysis of prescribing trends
 
Advertisement





 
   
Google
BioSpectrumAsia.com BioSpectrumIndia.com Web

About BioSpectrum | How to Advertise | Jobs at BioSpectrum | Jobs at CyberMedia | Contact Us | Privacy Statement



CyberMedia Network Websites


[Voice&Data]  [PCQuest]  [CIOL]  [Dataquest]  [Living Digital]  [IDC India]
[DQ Channels]  [The DQweek]  [CyberMedia Careers]  
[CyberMedia Events] [CyberMedia Digital]  [Cyber Astro]  [CyberMedia India]  [Global Services]  [BioSpectrum]

 
Copyrights are reserved for BioSpectrum ; Designed by : Altered Black